Seamus Mulligan leads $20m funding at medtech Avectas
Drug delivery specialist aims to be key player as medicine turns to cell technology and personalised medicine to tackle cancers
A maverick taking on the Irish whiskey establishment
Waterford Distillery founder Mark Reynier aims to produce the best single malt
Seamus Mulligan leads $10m funding for cell therapy start-up
Avectas has now raised $20m as it looks to unlock potential of personalised medicine
Meet the winning CEOs: Irish Times Business Person of the Month Awards
July, August and September winners of awards in association with KPMG
Business 2018: the winners and the losers
The last 12 months proved to be another year of mixed fortunes in corporate Ireland
Business person of the month: Séamus Mulligan, Adapt Pharma
Adapt agreed a $635m deal in August that will see it taken over by Emergen
What next for Séamus Mulligan?
Entrepreneur might turn attention to Maynooth University cancer therapy spinout
Making millions: how Irish team hit $735m jackpot with overdose rescue drug
US opioid crisis helped growth of overdose rescue drug marketed by Adapt Pharma
Six Irish men to share $635m after sale of drug firm
Adapt Pharma’s Narcan spray used in the front line of opioid crisis in United States
Jazz Pharma slips as it lowers full-year guidance
Irish drug group reports 27% rise in sales but profit slips and supply disruptions remain
Jazz Pharma named as Barclays stock pick for 2017
Drug firm with Athlone manufacturing plant seen as second fastest-growing US share
Diageo sold former Guinness brewery in Waterford for just €7.2m
Company accounts show Waterford Distillers recorded €564,214 loss last year
Jazz Pharma hits all the right notes
Jazz by name and jazzy by metaphor, the Irish firm is now a muscular player in the pharmaceutical world. ‘We specialise in devastating diseases’ says founder Bruce Cozadd
Adapt Pharma invests in Maynooth University tech spin-off
Profector Life Sciences has scientific instruments business selling devices that allow researchers to deliver molecules to cultured cells
Jazz Pharma reports strong second quarter growth
Revenue of $291.2 million, up almost 40 per cent year on year
Séamus Mulligan pumps $86m into new drug venture
Entrepreneur cashes in investment in Jazz Pharmaceuticals to fund new business
Jazz Pharmaceuticals invests €50m in manufacturing plant
Athlone project will create 50 high-skilled full-time jobs when completed by 2016.
Jazz pays $1bn for rare disease drug developer Gentium
Dublin pharma group continues expansion in specialty therapy sector
Jazz Pharma reported to be seeking $757.2m to refinance debt
Advisors for Dublin-based niche drug business hold meeting in New York today
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices